参考文献/References:
[1] Lan NSR,Fegan PG,Yeap BB,et al.Dyslipidaemia in adults with type 1 diabetes-when to treat?[J].Diabetes Metab Res Rev,2019,35(1):e3090.DOI:10.1002/dmrr.3090.
[2] Grill V.LADA:A type of diabetes in its own right[J].Curr diabetes Rev,2019,15(3):174-177. DOI:10.2174/1573399814666180716150905.
[3] Williams KV,Erbey JR,Becker D,et al. Can clinical factors estimate insulin resistance in type 1 diabetes?[J].Diabetes,2000,49(4):626-632.
[4] Marcadenti A,Fuchs FD,Moreira LB,et al.Adiposity phenotypes are associated with type-2 diabetes: LAP index, body adiposity index, and neck circumference[J].Atherosclerosis,2017,266:145-150.DOI:10.1016/j.atherosclerosis.2017.09.022.
[5] Touboul PJ,Hennerici MG,Meairs S,et al.Mannheim carotid intima-media thickness and plaque consensus(2004-2006-2011). An update on behalf of the advisory board of the 3rd, 4th and 5th watching the risk symposia, at the 13th, 15th and 20th European Stroke Conferences, Mannheim, Germany, 2004, Brussels, Belgium, 2006, and Hamburg, Germany, 2011[J].Cerebrovasc Dis,2012,34(4):290-296.DOI:10.1159/000343145.
[6] Soedamah-Muthu SS,Fuller JH,Mulnier HE,et al.High risk of cardiovascular disease in patients with type 1 diabetes in the U.K.: a cohort study using the general practice research database[J].Diabetes Care,2006,29(4):798-804.
[7] Wang P,Xu YY,Lv TT,et al.Subclinical atherosclerosis in patients with type 1 diabetes mellitus:a systematic review and meta-analysis[J].Angiology,2019,70(2):141-159.DOI:10.1177/0003319718787366.
[8] Hernández M,López C,Real J,et al.Preclinical carotid atherosclerosis in patients with latent autoimmune diabetes in adults(LADA), type 2 diabetes and classical type 1 diabetes[J].Cardiovasc Diabetol,2017,16(1):94.DOI:10.1186/s12933-017-0576-9.
[9] Sturlaugsdottir R,Aspelund T,Bjornsdottir G,et al.Carotid atherosclerosis and cardiovascular health metrics in old subjects from the AGES-Reykjavik study[J].Atherosclerosis,2015,242(1):65-70.DOI:10.1016/j.atherosclerosis.2015.06.043.
[10] Gudmundsson G,Margretardottir OB,Sigurdsson MI,et al. Airflow obstruction, atherosclerosis and cardiovascular risk factors in the AGES-Reykjavik study[J].Atherosclerosis,2016,252:122-127.DOI:10.1016/j.atherosclerosis.2016.07.919.
[11] Libby P,Loscalzo J,Ridker PM,et al.Inflammation, immunity, and infection in atherothrombosis: JACC review topic of the week[J].J Am Coll Cardiol,2018,72(17):2071-2081.DOI:10.1016/j.jacc.2018.08.1043.
[12] Buzzetti R,Zampetti S,Maddaloni E.Adult-onset autoimmune diabetes: current knowledge and implications for management[J].Nat Rev Endocrinol,2017,13(11):674-686.DOI:10.1038/nrendo.2017.99.
[13] Hirano T.Pathophysiology of diabetic dyslipidemia[J].J Atheroscler Thromb,2018,25(9):771-782.DOI:10.5551/jat.RV17023.
[14] Khoshdel AR,Eshtiaghi R.Assessment of arterial stiffness in metabolic syndrome related toinsulin resistance in apparently healthy men[J].Metab Syndr Relat Disord,2019,17(2):90-96.DOI:10.1089/met.2018.0090.
[15] Ding L,Peng K,Lin L,et al.The impact of fat distribution on subclinical coronary atherosclerosis in middle-aged Chinese adults[J].Int J Cardiol,2017,235:118-123.DOI:10.1016/j.ijcard.2017.02.082.
[16] Kyrou I,Panagiotakos DB,Kouli GM,et al.Lipid accumulation product in relation to 10-year cardiovascular disease incidence in Caucasian adults: the ATTICA study[J].Atherosclerosis,2018,279:10-16.DOI:10.1016/j.atherosclerosis.2018.10.015.